# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
RBC Capital analyst Ben Hendrix maintains Select Medical Hldgs (NYSE:SEM) with a Outperform and raises the price target from...
Benchmark analyst Bill Sutherland maintains Select Medical Hldgs (NYSE:SEM) with a Buy and raises the price target from $39 ...
Benchmark analyst Bill Sutherland reiterates Select Medical Hldgs (NYSE:SEM) with a Buy and maintains $39 price target.
Business OutlookSelect Medical is reaffirming its 2024 business outlook for revenue and adjusting its 2024 business outlook for...
Select Medical Hldgs (NYSE:SEM) reported quarterly earnings of $0.77 per share which beat the analyst consensus estimate of $0....
Benchmark analyst Bill Sutherland reiterates Select Medical Hldgs (NYSE:SEM) with a Buy and maintains $39 price target.
Concentra Group Holdings Parent, Inc. ("Concentra") today announced that it has confidentially submitted a draft regist...